Turkish hospitals utilize advanced drug-eluting stents (DES), bare-metal stents (BMS), and bioresorbable scaffolds that meet European and international standards. Leading cardiac centers in Istanbul and Ankara primarily use FDA-approved brands like Abbott Xience, Medtronic Resolute, and Boston Scientific Synergy to ensure low restenosis rates.
- Drug-eluting stents: Coated with medication to prevent artery re-narrowing, used in 95% of cases.
- Bare-metal stents: Uncoated stainless steel options reserved for patients with high bleeding risks.
- Bioresorbable scaffolds: Naturally dissolving implants designed for younger patients to allow vessel healing.
- International brands: Standard use of premium systems from Abbott, Medtronic, and Boston Scientific.
- Local innovation: Access to domestic next-generation options like the Atlas drug-released system.
Bookimed Expert Insight: While many countries use a mix of brands, Turkish private centers like Anadolu Medical Center and Memorial Şişli maintain a high density of premium drug-eluting stents. Data shows these JCI-accredited facilities favor the same Xience and Synergy systems used in top US hospitals, but deliver the procedure for significantly lower costs, specifically $9,000 compared to the $95,000 American average.
Patient Consensus: Patients report that private hospitals consistently provide premium drug-eluting stents as the standard. They advise confirming the specific brand and model in writing before the procedure to ensure it matches international medical travel standards.